Monitoring of Chronic Daily Headaches

  • Sam HooshmandEmail author
  • Fallon C. Schloemer


This chapter discusses the various metrics used in monitoring patients with chronic daily headache (CDH). Topics such as office visits, psychiatric assessments, vitals, physical exam, laboratory data, radiological imaging, standardized scales, and headache diaries will all be reviewed. To date a comprehensive collection of such information has yet to be compiled. The intent of this chapter is to provide information that can be used as a guide for monitoring those afflicted with chronic daily headaches, regardless of the type, and therefore allow for personalized treatment.


Chronic daily headache Headache diaries Office visits Multidisciplinary therapy Physical exam Mental health monitoring Laboratory assessments Radiographical monitoring Monitoring drug levels Specialized testing 


  1. 1.
    Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47(4):871–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRefGoogle Scholar
  3. 3.
    Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006;354(2):158–65.CrossRefPubMedGoogle Scholar
  4. 4.
    Lanteri-Minet M, et al. Prevalence and description of chronic daily headache in the general population in France. Pain. 2003;102(1–2):143–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Lu SR, et al. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21(10):980–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Scher AI, et al. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.CrossRefPubMedGoogle Scholar
  7. 7.
    Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.CrossRefPubMedGoogle Scholar
  8. 8.
    Wiendels NJ, et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia. 2006;26(12):1434–42.CrossRefPubMedGoogle Scholar
  9. 9.
    Lanteri-Minet M, et al. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50.CrossRefPubMedGoogle Scholar
  10. 10.
    Hu XH, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159(8):813–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Abu Bakar N, et al. Quality of life in primary headache disorders: a review. Cephalalgia. 2016;36(1):67–91.CrossRefPubMedGoogle Scholar
  12. 12.
    Gunreben-Stempfle B, et al. Effectiveness of an intensive multidisciplinary headache treatment program. Headache. 2009;49(7):990–1000.CrossRefPubMedGoogle Scholar
  13. 13.
    Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 2002;42(9):845–54.CrossRefPubMedGoogle Scholar
  14. 14.
    Maizels M, Saenz V, Wirjo J. Impact of a group-based model of disease management for headache. Headache. 2003;43(6):621–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Saper JR, et al. Comprehensive/tertiary care for headache: a 6-month outcome study. Headache. 1999;39(4):249–63.CrossRefPubMedGoogle Scholar
  16. 16.
    Wallasch TM, Kropp P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain. 2012;13(7):521–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Harpole LH, et al. Headache management program improves outcome for chronic headache. Headache. 2003;43(7):715–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Gaul C, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain. 2011;12(4):475–83.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Gaul C, et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain. 2011;12(5):511–9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Sahai-Srivastava S, et al. Multidisciplinary team treatment approaches to chronic daily headaches. Headache. 2017;57(9):1482–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Butcher, J. N., Dahlstrom, W. G., Graham, J. R., Tellegen, A., & Kaemmer, B. Minnesota Multiphasic Personality Inventory–2 (MMPI-2): Manual for administration and scoring. Minneapolis, MN: University of Minnesota Press. 1989.Google Scholar
  22. 22.
    Amoils S, et al. The positive impact of integrative medicine in the treatment of recalcitrant chronic daily headache: a series of case reports. Glob Adv Health Med. 2014;3(4):45–54.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Juang KD, et al. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache. 2000;40(10):818–23.CrossRefPubMedGoogle Scholar
  24. 24.
    Couch JR. Update on chronic daily headache. Curr Treat Options Neurol. 2011;13(1):41–55.CrossRefPubMedGoogle Scholar
  25. 25.
    Verri AP, et al. Psychiatric comorbidity in chronic daily headache. Cephalalgia. 1998;18(Suppl 21):45–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Grisanzio KA, et al. Transdiagnostic symptom clusters and associations with brain, behavior, and daily function in mood, anxiety and trauma disorders. JAMA Psychiat. 2017;75(2):201–9.CrossRefGoogle Scholar
  27. 27.
    Spitzer RL, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749–56.CrossRefPubMedGoogle Scholar
  28. 28.
    Beck, A.T., Steer, R.A., & Brown, G.K. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation. 1996.Google Scholar
  29. 29.
    Steer RA, et al. Use of the beck depression inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry. 1999;21(2):106–11.CrossRefPubMedGoogle Scholar
  30. 30.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck anxiety inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444–58.CrossRefPubMedGoogle Scholar
  32. 32.
    Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Schurks M, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Scher AI, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005;64(4):614–20.CrossRefPubMedGoogle Scholar
  35. 35.
    Kirkham KE, Colon RJ, Solomon GD. The role of cardiovascular screening in headache patients. Headache. 2011;51(2):331–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Scher AI, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1–2):81–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep. 2008;12(3):207–12.CrossRefPubMedGoogle Scholar
  38. 38.
    Bigal ME, et al. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68(21):1851–61.CrossRefPubMedGoogle Scholar
  39. 39.
    Friedman M, et al. Diagnostic value of the Friedman tongue position and Mallampati classification for obstructive sleep apnea: a meta-analysis. Otolaryngol Head Neck Surg. 2013;148(4):540–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology. 2003;60(8):1366–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Giamberardino MA, et al. Contribution of myofascial trigger points to migraine symptoms. J Pain. 2007;8(11):869–78.CrossRefPubMedGoogle Scholar
  42. 42.
    Ferrari A, et al. Monitoring of adherence to headache treatments by means of hair analysis. Eur J Clin Pharmacol. 2017;73(2):197–203.CrossRefPubMedGoogle Scholar
  43. 43.
    Practice parameter: the electroencephalogram in the evaluation of headache (summary statement). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 1995;45(7):1411–3.Google Scholar
  44. 44.
    Russell MB, et al. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992;12(6):369–74.CrossRefPubMedGoogle Scholar
  45. 45.
    Goldberg J, et al. Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs. Headache. 2007;47(3):384–96.PubMedGoogle Scholar
  46. 46.
    Nappi G, et al. Diaries and calendars for migraine. A review. Cephalalgia. 2006;26(8):905–16.CrossRefPubMedGoogle Scholar
  47. 47.
    Hundert AS, et al. Commercially available mobile phone headache diary apps: a systematic review. JMIR Mhealth Uhealth. 2014;2(3):e36.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurologyFroedtert and the Medical College of WisconsinMilwaukeeUSA

Personalised recommendations